TACI-Associated Common Variable Immunodeficiency (TNFRSF13B) Sequencing
2007569
Ordering Recommendation
Use to identify TNFRSF13B mutations in individuals with clinical phenotype for common variable immunodeficiency.
Mnemonic
TACI FGS
Methodology
Polymerase Chain Reaction/Sequencing
Performed
Varies
Reported
3-4 weeks  
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Specimen Required
Patient Preparation
  
Collect
Lavender (EDTA), pink (K2 EDTA), or yellow (ACD Solution A or B).  
Specimen Preparation
Transport 3 mL whole blood. (Min: 1 mL)  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
  
Remarks
  
Stability
Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable  
Reference Interval
By report  
Interpretive Data
 
Note
 
CPT Code(s)
81479
Components
Component Test Code*Component Chart Name
2007570TACI-Assoc CVID (TNFRSF13B) Seq Specimen
2007571TACI-Assoc CVID (TNFRSF13B) Seq Interp
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Antibody deficiency due to TACI defect
  • CVID/CVID2
  • Hypogammaglobulinemia due to TACI deficiency
  • IgA deficiency
  • IGAD2
  • Immunoglobulin A deficiency Sequencing
  • Selective IgA deficiency-2
  • TNFRSF13B
  • Tumor necrosis factor receptor superfamily, member13B